This activity is hosted on the site of our educational partner

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

  • Overview
  • Pre-Assessment
  • Activity
  • Post-Test
  • Evaluation
  • Claim Credit
Questions about our CME?
Questions about our CME?
Improving the Quality of Care for Patients with Atopic Dermatitis: Integrating Measurement-Based Tools Into Your Clinical Practice

Improving the Quality of Care for Patients with Atopic Dermatitis: Integrating Measurement-Based Tools Into Your Clinical Practice

Format

Webcast

Time to Complete

1.50 hours

Released

January 17, 2019

Expires

January 17, 2020
Add to Queue


Maximum Credits

1.50 / AMA PRA Category 1 CreditsTM
1.50 / ABIM MOC Points
1.50 / CNE Contact Hours
1.50 / CE for Pharmacists (0.15 CEUs)

Accredited Provider


This educational initiative is provided by CME Outfitters.

Commercial Supporter

Supported by an educational grant from Sanofi Genzyme and Regeneron Pharmaceuticals.

Program Description

Attitudes about atopic dermatitis are evolving with the emergence of new and effective treatments. With the average dermatologist having not enjoyed caring for patients with AD for decades, there is little to no consensus in current practice about validated tools to assess and monitor the severity of the diseases and no consistent use of diagnostic or assessment tools. This lack of knowledge and education leads to confusion, poor recognition, and absence of assessment of AD severity.

The use of patient-reported outcomes such as the Patient-Oriented Eczema Measure (POEM) are often underused in clinical practice despite being simple, valid, repeatable, and easy to interpret. The use of tools such as POEM is important to capture the impact of AD on health-related quality of life.

In this CME Outfitters Live and On Demand, expert faculty will discuss diagnostic assessment and measurement of symptom severity in AD including patient-reported outcomes, with the goal of educating clinicians regarding tools for diagnosis and assessment that can be integrated into their clinical practice.

Intended Audience

Dermatologists, allergists, primary care physicians, physician assistants, nurse practitioners, nurses, and pharmacists who treat patients with atopic dermatitis.

Educational Objectives

At the end of this CME/CE activity, participants should be able to:

Physicians/PAs

  • Apply the Hanifin Rajka criteria and/or the American Academy of Dermatology (AAD) criteria to facilitate the diagnosis of AD in clinical practice
  • Incorporate the POEM assessment scale into clinical practice to monitor disease severity and response to treatment.
  • Document the utilization of clinical assessment tools and results form their use in patients' charts.

CNE/CPE

  • Summarize the Hanifin Rajka criteria and/or the American Academy of Dermatology (AAD) criteria used to diagnose AD.
  • Describe the POEM assessment scale for monitoring disease severity and response to treatment.
  • Identify the tools and clinical assessment results that should be documented in patients' charts.

Conflict Of Interest Disclosure Policy

It is the policy of CME Outfitters, LLC, to ensure independence, balance, objectivity, and scientific rigor and integrity in all of their CE activities. Faculty must disclose to the participants any relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of this CE activity. CME Outfitters, LLC, has evaluated, identified, and attempted to resolve any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer review process. The following information is for participant information only. It is not assumed that these relationships will have a negative impact on the presentations.

Faculty

Zelma C. Chiesa Fuxench, MD, MSCE (Moderator)
Assistant Professor of Dermatology
Department of Dermatology
University of Pennsylvania Perelman School of Medicine
Philadelphia, PA

Dr. Chiesa Fuxench discloses that she serves on the Advisory Board for Sanofi Genzyme and Regeneron Pharmaceuticals.

Stephen D. Hess, MD, PhD
President / Medical Director
Center City Dermatology
Clinical Associate in Dermatology
Department of Dermatology
Hospital of the University of Pennsylvania
Philadelphia, PA

Dr. Hess discloses he is on the Speakers Bureau for Celgene Corporation; Janssen Pharmaceuticals, Inc.; Pfizer Inc.; Sanofi Genzyme and Regeneron Pharmaceuticals; and Sun Pharmaceutical Industries Ltd. He is a consultant for Celgene Corporation; Janssen Pharmaceuticals, Inc.; and Verrica Pharmaceuticals. He is a stock shareholder (directly purchased) for Aclaris Therapeutics, Inc; Celgene Corporation; and Verrica Pharmaceuticals.

John J. Russell, MD
Clinical Professor of Family and Community Medicine
Sydney Kimmel Medical College
Thomas Jefferson University School of Medicine
Philadelphia, PA
Program Director
Family Medicine Residency Program
Abington Hospital - Jefferson Health
Abington, PA

Dr. Russell discloses he is on the Speakers Bureau and a consultant for Sanofi.

Jonathan I. Silverberg, MD, PhD, MPH
Associate Professor of Dermatology, Medical Social Sciences and Preventive Medicine
Northwestern University Feinberg School of Medicine
Director, Northwestern Medicine Multidisciplinary Eczema Center
Director, Contact Dermatitis Clinic, Northwestern Memorial Hospital
Chicago, IL

Dr. Silverberg reports that he receives grants from GlaxoSmithKline and receives research support for Sanofi Genzyme and Regeneron Pharmaceuticals. He is a consultant for AbbVie Inc.; Anaptys Bio, Inc; Asana BioSciences, LLC; Dermavant Sciences, Inc.; Eli Lilly and Company; Incyte Corporation; Galderma; GlaxoSmithKline; Glenmark Pharmaceutical Inc.; Kiniksa Pharmaceuticals; LEO Pharma Inc.; Menlo Therapeutics; Pfizer Inc.; Realm Therapeutics, Inc.; and Sanofi Genzyme and Regeneron Pharmaceuticals .

Accredited Provider Disclosure

The CME Outfitters, LLC staff has nothing to disclose.

Planners' and Managers' Disclosures

Jeffrey Helfand, DO, MS, (peer reviewer) has no disclosures to report.
Mae Ochoa, RPh, (peer reviewer) has no disclosures to report.
Kate Nelson, PHD, (planning committee) has no disclosures to report.
Jan Perez (planning committee) has no disclosures to report.
Sharon Tordoff (planning committee) has no disclosures to report.

Credit

1.50

Type

AMA PRA Category 1 Credit(s)TM

Accreditation Statement

CME Outfitters, LLC is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Designation Statement

CME Outfitters, LLC, designates this enduring material for a maximum of 1.50 AMA PRA Category 1 CreditsTM  . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Credit

1.50

Type

AMA PRA Category 1 Credit(s)TM /ABIM MOC point(s)

Accreditation Statement

CME Outfitters, LLC is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Designation Statement

CME Outfitters, LLC, designates this enduring material for a maximum of 1.50 AMA PRA Category 1 CreditsTM  . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ABIM MOC Part II Points:
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.50 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Credit

1.50

Type

CNE Contact Hour(s)

Accreditation Statement

CME Outfitters, LLC, is approved by the California Board of Registered Nursing.

Designation Statement

Provider approved by the California Board of Registered Nursing, Provider Number CEP 15510, for 1.50 contact hours

Credit

1.50

Type

CE for Pharmacists

Accreditation Statement

CME Outfitters, LLC, is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.1.50 contact hours (0.15 CEUs)

Universal Activity Number: 0376-0000-18-025-H01-P

Type: Knowledge-based

Additional Credit Information

Note to Nurse Practitioners: Nurse practitioners can apply for AMA PRA Category 1 CreditTM   through the American Academy of Nurse Practitioners (AANP). AANP will accept AMA PRA Category 1 CreditTM   from organizations accredited by the Accreditation Council for Continuing Medical Education. Nurse practitioners can also apply for credit through their state boards.

Note to Physician Assistants: AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 CreditTM   from organizations accredited by the Accreditation Council for Continuing Medical Education.

Disclosure of Unlabeled Use

Faculty of this CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management.

Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Instructions

There are no fees for participating in this CME/CE activity. To receive credit, participants must (1) read the learning objectives and disclosure statements, (2) study the educational activity, and (3) complete the post-test and activity evaluation form, including the certificate information section.

To obtain a certificate, participants must receive a score of 75% or better on the post-test. The post-test can be accessed at the end of the activity. Your online certificate will be saved on myCME within your Profile/CME History, which you can access at any time.

If you have any questions relating to the accreditation of this activity, please contact CME Outfitters at 877-263-7767.

If you have any other questions relating to your certificate or other issues with this activity, please contact myCME.Support@haymarketmedical.com.

SYSTEM REQUIREMENTS

Hardware and Software Requirements
  • A computer with an internet connection
  • Internet Browser: Internet Explorer 7.x or higher, Firefox 4.x or higher, Safari 2.x or higher, or any other W3C standards compliant browser
  • Additional Software: Adobe Flash Player and/or an HTML 5 capable browser maybe required for video or audio playback. PowerPoint or Adobe Acrobat Reader may occasionally be required
Add to Queue